(Q47930493)

English

Relationships Between Pharmacokinetics and Rate of Bone Turnover After Intravenous Bisphosphonate (Olpadronate) in Patients With Paget's Disease of Bone

scientific article published on May 1, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

Relationships Between Pharmacokinetics and Rate of Bone Turnover After Intravenous Bisphosphonate (Olpadronate) in Patients With Paget's Disease of Bone (English)

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Orthopedics and sports medicine

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

pharmacokinetics

1 reference

based on heuristic

inferred from title

Elisabeth M Eekhoff

2

object named as

Marelise E. M W. Eekhoff

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733726

30 December 2023

author name string

Jan Den Hartigh

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

Pieter Vermeij

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

Serge C. L M. Cremers

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733726

30 December 2023

Neveen A. T. Hamdy

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733726

30 December 2023

Socrates E. Papapoulos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733726

30 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12733726

30 December 2023

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1359%2Fjbmr.2003.18.5.868

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

https://onlinelibrary.wiley.com/doi/full/10.1359/jbmr.2003.18.5.868

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

18

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

868-875

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

Measurement of the renal clearance of drugs

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.5.868

21 January 2018

Bisphosphonates: mechanisms of action

1

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.

2

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group

3

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate

5

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Short-term therapy with oral olpadronate in active Paget's disease of bone

6

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

A pharmacokinetic/pharmacodynamic comparison of SAAM II and PC/WinNonlin modeling software.

9

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Semi-automatic liquid chromatographic analysis of olpadronate in urine and serum using derivatization with (9-fluorenylmethyl)chloroformate

11

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

A specific method for the analysis of hydroxyproline in tissues and urine

12

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover

13

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Bisphosphonate space measurement in Paget's disease of bone treated with APD.

14

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis

15

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Factors that determine intensity of response to treatment with tiludronate in Paget's disease

16

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis

17

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis

18

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Retention of etidronate in human, dog, and rat

19

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships

20

1 reference

10.1359/JBMR.2003.18.5.868

https://api.crossref.org/works/10.1359/JBMR.2003.18.5.868

30 December 2023

Identifiers

10.1359/JBMR.2003.18.5.868

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

release_hu7oyltntzfmdpgkymwks3v264

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12733726

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47930493&oldid=2144623555"